Global Crossing Airlines Group Inc. (NEO:JET)

Market Cap	52.88M
Revenue (ttm)	339.96M
Net Income (ttm)	-7.10M
Shares Out	64.49M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,500
Average Volume	15,346
Open	0.8200
Previous Close	0.8200
Day's Range	0.8200 - 0.8400
52-Week Range	0.5500 - 1.1500
Beta	0.87
RSI	53.89
Earnings Date	Aug 7, 2025

About Achilles Therapeutics

Global Crossing Airlines Group Inc. provides air transport services in the United States, Europe, Canada, and Central and South America. It operates a US Part 121 flag and supplemental airline using the Airbus A320 family of aircraft and the Airbus A321 freighter. The company is involved in the provision of an aircraft, crew, maintenance, and insurance services using wet lease contracts to airlines and non-airlines; and cargo and passenger aircraft charter services. It also leases office space; operates its ticket counters; and maintains a main...

• Industry: Airlines
• Sector: Industrials
• Employees: 678
• Stock Exchange: Cboe Canada
• Ticker Symbol: JET

Financial Performance

In 2024, NEO:JET's revenue was $223.75 million, an increase of 39.74% compared to the previous year's $160.12 million. Losses were -$11.47 million, -45.40% less than in 2023.